ReWalk Robotics Ltd. (NASDAQ:LFWD) Director Joseph E. Turk, Jr. Purchases 6,000 Shares of Stock

ReWalk Robotics Ltd. (NASDAQ:LFWD) Director Joseph E. Turk, Jr. purchased 6,000 shares of the company’s stock in a transaction on Friday, December 13th. The stock was bought at an average price of $1.69 per share, for a total transaction of $10,140.00. Following the completion of the purchase, the director now directly owns 18,516 shares of the company’s stock, valued at $31,292.04. The trade was a 47.94 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

ReWalk Robotics Stock Down 1.2 %

Shares of NASDAQ LFWD opened at $1.61 on Wednesday. The business has a 50-day moving average price of $2.19 and a 200 day moving average price of $3.18. The stock has a market cap of $14.18 million, a PE ratio of -0.65 and a beta of 2.04. ReWalk Robotics Ltd. has a 52-week low of $1.51 and a 52-week high of $9.10.

ReWalk Robotics (NASDAQ:LFWD) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($0.35) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.08). The firm had revenue of $6.13 million during the quarter, compared to analyst estimates of $8.38 million. ReWalk Robotics had a negative net margin of 77.21% and a negative return on equity of 43.02%. During the same period in the previous year, the company posted ($0.56) earnings per share. Sell-side analysts anticipate that ReWalk Robotics Ltd. will post -1.78 earnings per share for the current year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in ReWalk Robotics stock. Dimensional Fund Advisors LP bought a new position in shares of ReWalk Robotics Ltd. (NASDAQ:LFWD) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned 0.16% of ReWalk Robotics as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 26.76% of the company’s stock.

Analyst Ratings Changes

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $13.00 target price on shares of ReWalk Robotics in a research report on Wednesday, November 13th.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.